State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
7
Page:
207-217
Author(s):
Stella Bernardi, Paola Secchiero and Giorgio Zauli
NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
239-246
Author(s):
Mingming Zou, Lei Zhang, Yuanchao Xie and Wenfang Xu
Chemotherapeutic Targeting of Cell Death Pathways
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
226-238
Author(s):
Sylvia Mansilla, Laia Llovera and Jose Portugal
Thrombomodulin Links Coagulation to Inflammation and Immunity
Journal:
Current Drug Targets
Volume:
13
Page:
421-431
Author(s):
John Morser
The Stem Cell Niche as a Pharmaceutical Target for Prevention of Skeletal Metastases
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
187-193
Author(s):
John M. Chirgwin
Clinical Vignettes: Integrated Care of Cancer Patients by Oncologists and Cardiologists
Journal:
Current Cardiology Reviews
Volume:
7
Page:
258-261
Author(s):
Erin Hofstatter, Hamid Saadati, Kerry Russell and Raymond Russell
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Journal:
Current Cardiology Reviews
Volume:
7
Page:
214-220
Author(s):
Maria Volkova and Raymond Russell
Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
107-123
Author(s):
S. A. Kono, L. E. Heasley, R. C. Doebele and D. R. Camidge
The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
85-96
Author(s):
L. A. Stivala, O. Cazzalini and E. Prosperi
Polysaccharide-K (PSK) in Cancer - Old Story, New Possibilities?
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
757-762
Author(s):
C. Sun, A.H. Rosendahl, X.D. Wang, D.Q. Wu and R. Andersson